SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-079835
Filing Date
2021-03-12
Accepted
2021-03-12 17:11:52
Documents
9
Effectiveness Date
2021-03-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR d154330ds3asr.htm S-3ASR 434363
2 EX-1.2 d154330dex12.htm EX-1.2 206796
3 EX-4.2 d154330dex42.htm EX-4.2 277045
4 EX-4.3 d154330dex43.htm EX-4.3 276612
5 EX-5.1 d154330dex51.htm EX-5.1 13317
6 EX-5.2 d154330dex52.htm EX-5.2 7512
7 EX-23.1 d154330dex231.htm EX-23.1 1759
8 GRAPHIC g154330g0311132120873.jpg GRAPHIC 2755
9 GRAPHIC g154330g04v04.jpg GRAPHIC 65321
  Complete submission text file 0001193125-21-079835.txt   1308801
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-254237 | Film No.: 21738450
SIC: 2834 Pharmaceutical Preparations